CINCINNATI--(BUSINESS WIRE)--Eyas Medical Imaging is proud to announce the first installation of the groundbreaking neonatal Magnetic Resonance Imaging (MRI) system, the Ascent3T™, within the neonatal intensive care unit (NICU) at Cincinnati Children’s.
While the Ascent3T is not yet cleared by the U.S. Food and Drug Administration (FDA) for commercial use in the United States, Eyas has selected Cincinnati Children’s to conduct research studies involving the Ascent3T Neonatal MRI System. Eyas hopes to apply to the FDA for 510(k) clearance in the near future, allowing healthcare providers and neonatal patients to benefit from this technology.
The Ascent3T utilizes a 3 Tesla (3T) magnet, providing a magnetic field strength previously unavailable in neonatal MRI systems. A 3T magnet enables a more comprehensive and precise diagnostic tool, providing healthcare professionals with detailed imaging of vital organs, including the brain, lungs, heart, and abdomen. A 3T MRI system offers unmatched accuracy in neonatal diagnostics, paving the way for enhanced treatment plans and improved patient outcomes for vulnerable infants.
Ad Statistics
Times Displayed: 188702
Times Visited: 5644 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
The Ascent3T solves a huge access problem by allowing direct installation within the neonatal unit, eliminating the risk of transporting fragile newborns to alternate MRI locations within the hospital. Its compact footprint and innovative engineering are designed specifically for infant anatomy. Upon FDA clearance, the Ascent3T will give infants the same access and standard of care provided to adults by conventional MRI systems.
Conceived by MR physicist Charles Dumoulin, Ph.D., a professor of Pediatrics and Radiology at Cincinnati Children’s, this innovation represents a significant advancement in neonatal imaging and is set to transform the way healthcare professionals evaluate newborns. He expressed his excitement, stating, "The Ascent3T brings an unprecedented level of MR imaging and access to our smallest patients. By reinventing MRI technology, doctors can now visualize and understand neonatal health conditions using state-of-the-art MR imaging tailored to infants. It is a tremendous opportunity for better-informed medical decisions and improved neonatal care.” Dr. Dumoulin is the founder and CTO of Eyas and has a financial interest in the success of this project.
Abram Gordon, who serves as vice president of Cincinnati Children’s Innovation Ventures, which focuses on technology transfer and commercialization, added: “This is a significant technological advancement for our most vulnerable patients and validates the high level of innovation and problem-solving happening right here in Cincinnati. This new MRI solution is a direct output from Cincinnati Children’s and further evidence of the incredible people and ideas generated here in our region.”
